Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today's Clinician
Explore this paper's citation graph
Summary
The evidence confirming polycystic ovary syndrome (PCOS) as a cardiovascular health threat is systematically addressed and recommendations for management of women with PCOS should deviate from guidelines for the population at large are reviewed.
- Type
- review
- Published
- 2007-03-01
- Cited by
- 45
- References
- 60
- OpenAlex
- https://openalex.org/W2040617246
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:33491095
Keywords
Medicine, Polycystic ovary, Diabetes mellitus, Population, Disease
References
- Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
- Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone.
- Impaired glucose tolerance--prevalence and conversion to NIDDM.
- Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
- Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.
- Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
- Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
- A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills.
- Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.
- Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
- Detecting Insulin Resistance in Polycystic Ovary Syndrome: Purposes and Pitfalls
- Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome.
- Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome.
- Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
- Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
- Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects.
- The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
- Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.
- Effect of exercise duration and intensity on weight loss in overweight, sedentary women: a randomized trial.
- Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Cited by
- Polycystic ovary syndrome update in adolescence
- Diagnosis and Management of Polycystic Ovary Syndrome: A Literature Review
- Recognizing polycystic ovary syndrome in the primary care setting
- Metformin 2,500 mg/day in the treatment of obese women with polycystic ovary syndrome and its effect on weight, hormones, and lipid profile
- Subclinical inflammation in obese women with polycystic ovary syndrome
- Polycystic ovary syndrome: A follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15–25 years after ovarian wedge resection
- Comparative Pharmacokinetic Study between Metformin Alone and Combined with Orlistat in Healthy Mexican Volunteers
- Vascular abnormalities and low-grade chronic inflammation in women with polycystic ovary syndrome: Relationships with insulin resistance, obesity and hyperandrogenemia
- Dietary approaches for polycystic ovary syndrome
- Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome
- Oxidative stress in non-obese women with polycystic ovarian syndrome.
- Polycystic Ovary Syndrome in Adolescence
- A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
- Polycystic ovary syndrome (PCOS).
- Polycystic ovary syndrome: challenges in adolescence.
- Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome
- Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
- The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome
- MARKERS OF OXIDATIVE STRESS AND SERUM LIPIDS IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
- The Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Androgen Status in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials
Related papers
- Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome
- Controversies in the diagnosis of polycystic ovary syndrome
- Polycystic ovary syndrome in obese adolescents
- Gherlin expression in women with polycystic ovary syndrome--a preliminary study.
- Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study.
- Study on the obesity and insulin resistance of polycystic ovary syndrome
- Insulin resistance in pregnant women with and without polycystic ovary syndrome, and measures of body composition in offspring at birth and three years of age
- Diet and Polycystic Ovary Syndrome.
- Phosphatidylinositide-3 kinase: a newer molecular target in metabolic and hormonal pathway of polycystic ovary syndrome.